S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis

S100B is an astrocytic protein behaving at high concentration as a damage-associated molecular pattern molecule. A direct correlation between the increased amount of S100B and inflammatory processes has been demonstrated, and in particular, the inhibitor of S100B activity pentamidine has been shown to ameliorate clinical scores and neuropathologic-biomolecular parameters in the relapsing-remitting experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. This study investigates the effect of arundic acid (AA), a known inhibitor of astrocytic S100B synthesis, in the chronic experimental autoimmune encephalomyelitis, which is another mouse model of multiple sclerosis usually studied. By the daily evaluation of clinical scores and neuropathologic-molecular analysis performed in the spinal cord, we observed that the AA-treated group showed lower severity compared to the vehicle-treated mice, particularly in the early phase of disease onset. We also observed a significant reduction of astrocytosis, demyelination, immune infiltrates, proinflammatory cytokines expression and enzymatic oxidative reactivity in the AA-treated group. Overall, our results reinforce the involvement of S100B in the development of animal models of multiple sclerosis and propose AA targeting the S100B protein as a focused potential drug to be considered for multiple sclerosis treatment.     

Mediation of the Cardioprotective Effects of Mannitol Discovered,with Refutation of Common Protein Kinases

The osmodiuretic agent Mannitol exerts cardioprotection against ischemia and reperfusion (I/R) injury when applied as a pre- and/or postconditioning stimulus. Previously, we demonstrated that these properties are mediated via the activation of mitochondrial ATP-sensitive potassium (mK_ATP) channels. However, considering Mannitol remains in the extracellular compartment, the question arises as to which receptor and intracellular signaling cascades are involved in myocardial protection by the osmodiuretic substance. Protein kinase B (Akt) and G (PKG), as part of the reperfusion injury salvage kinase (RISK) and/or endothelial nitric oxide (eNOS)/PKG pathway, are two well-investigated intracellular targets conferring myocardial protection upstream of mitochondrial potassium channels. Adenosine receptor subtypes have been shown to trigger different cardioprotective pathways, for example, the reperfusion injury. Further, Mannitol induces an increased activation of the adenosine 1 receptor (A1R) in renal cells conferring its nephroprotective properties. Therefore, we investigated whether (1) Akt and PKG are possible signaling targets involved in Mannitol-induced conditioning upstream of the mK_ATP channel and/or whether (2) cardioprotection by Mannitol is mediated via activation of the A1R. All experiments were performed on male Wistar rats in vitro employing the Langendorff isolated heart perfusion technique with infarct size determination as the primary endpoint. To unravel possible protein kinase activation, Mannitol was applied in combination with the Akt (MK2206) or PKG (KT5823) inhibitor. In further groups, an A1R blocker (DPCPX) was given with or without Mannitol. Preconditioning with Mannitol (Man) significantly reduced the infarct size compared to the control group. Co-administration of the A1R blocker DPXPC fully abolished myocardial protection of Mannitol. Interestingly and in contrast to the initial hypothesis, neither administration of the Akt nor the PKG blocker had any impact on the cardioprotective properties of Mannitol-induced preconditioning. These results are quite unexpected and show that the protein kinases Akt and PKG—as possible targets of known protective signaling cascades—are not involved in Mannitol-induced preconditioning. However, the cardioprotective effects of Mannitol are mediated via the A1R.     

Constructor theory of life

Neo-Darwinian evolutionary theory explains how the appearance of purposive design in the adaptations of living organisms can have come about without their intentionally being designed. The explanation relies crucially on the possibility of certain physical processes: mainly, gene replication and natural selection. In this paper, I show that for those processes to be possible without the design of biological adaptations being encoded in the laws of physics, those laws must have certain other properties. The theory of what these properties are is not part of evolution theory proper, yet without it the neo-Darwinian theory does not fully achieve its purpose of explaining the appearance of design. To this end, I apply constructor theory''s new mode of explanation to express exactly within physics the appearance of design, no-design laws, and the logic of self-reproduction and natural selection. I conclude that self-reproduction, replication and natural selection are possible under no-design laws, the only non-trivial condition being that they allow digital information to be physically instantiated. This has an exact characterization in the constructor theory of information. I also show that under no-design laws an accurate replicator requires the existence of a ‘vehicle’ constituting, together with the replicator, a self-reproducer.     

Catalyst deactivation in on-board H2 production by fuel dehydrogenation

The production of H₂ for on-board application is a very interesting challenge for industrial and academic researchers. The aim is the application of on-board hydrogen production on the airplanes using kerosene as H₂ source. In this work an in depth study into the partial dehydrogenation (PDH) of two hydrocarbons blends and desulfurized JetA1 fuel has been performed by using 1 wt.%Pt–1 wt.%Sn/γ-Al₂O₃ and 1 wt.%Pt–1 wt.%Sn–0.5%K/γ-Al₂O₃ to find a way to produce H₂ “on-board” for the feeding of the fuel-cell apparatus. The mechanism of deactivation by coke was studied in depth combining Raman spectroscopy and Temperature-programmed oxidation (TPO) analyses. Microstructure analysis of metallic particles in fresh and deactivated catalysts was investigated by HRTEM. Relatively high H₂ partial pressure increases catalyst life by controlling full dehydrogenation coke-forming reaction. By feeding model organic molecules, it was possible to identify the contribution of each class of compounds to the H₂ production as well as the amount and type of coke formed. A relatively complex reaction pathway, which is able to evidence the role of different sites and reactions involved in PDH processes, was proposed.     

Destabilization of LiBH4 by nanoconfinement in PMMA–co–BM polymer matrix for reversible hydrogen storage

Destabilization of LiBH₄ by nanoconfinement in poly (methyl methacrylate)–co–butyl methacrylate (PMMA–co–BM), denoted as nano LiBH₄–PMMA–co–BM, is proposed for reversible hydrogen storage. The onset dehydrogenation temperature of nano LiBH₄–PMMA–co–BM is reduced to ∼80 °C (ΔT = 340 and 170 °C as compared with milled LiBH₄ and nanoconfined LiBH₄ in carbon aerogel, respectively). At 120 °C under vacuum, nano LiBH₄–PMMA–co–BM releases 8.8 wt.% H₂ with respect to LiBH₄ content within 4 h during the 1st dehydrogenation, while milled LiBH₄ performs no dehydrogenation at the same temperature and pressure condition. Moreover, nano LiBH₄–PMMA–co–BM can be rehydrogenated at the mildest condition (140 °C under 50 bar H₂ for 12 h) among other modified LiBH₄ reported in the previous literature. Due to the hydrophobicity of PMMA–co–BM host, deterioration of LiBH₄ by oxygen and humidity in ambient condition is avoided after nanoconfinement. Although the interaction between LiBH₄ and the pendant group of PMMA–co–BM leads to a reduced hydrogen storage capacity, significant destabilization of LiBH₄ is accomplished.     

NaAlH4 production from waste aluminum by reactive ball milling

Due to its thermodynamic properties and high reversibility, Ti doped sodium alanate is considered as a prototype hydrogen storage material. In this work we show how sodium alanate can be synthesized by reactive ball milling using aluminum particles obtained from recycled waste incineration slag. The synthesis was monitored with an in situ milling vial and characterized stepwise by PXD and DTA analyses. The sorption properties of the material were investigated using in situ synchrotron radiation PXD and volumetric analyses. A complete conversion of the starting reactants was obtained.     

Formulation study of a patch containing propranolol by design of experiments

Objective: To evaluate the feasibility of a transdermal patch containing propranolol (PR).

Method: Skin penetration enhancers (SPEs) able to improve the skin permeability of PR were selected and a quality by design approach was applied to the development of the patch by a 2⁴ full factorial design. The permeation profile of PR from the formulations was assessed in in vitro permeation studies performed by using Franz diffusion cells and human epidermis as membrane. Finally, skin irritation was evaluated by the Draize test.

Results: N-methyl pyrrolidone (NMP) resulted as the best SPE: in addition, the critical factors influencing the PR diffusion through the human epidermis when loaded in the patch resulted in the matrix thickness (X₁, p?=?0.0957) and PR content (X₃, p?=?0.0004) which improved the flux; conversely, NMP lacked its enhancement effect when loaded in the patch and the increase in its concentration (X₄, p?=?0.006) affected the drug permeation through human epidermis. The flux of optimal formulation was 12.7?μg/cm²/h. On the basis of the steady-state concentration and clearance of PR, the estimated patch surface was 100–120 cm², since the activity of PR is related to its Senantiomer and no in vivo bioconversion occurs.

Conclusion: A patch containing (S)-PR was prepared and the (S)-PR flux (13.3?μg/cm²/h) permitted to confirm the suitability of a transdermal administration of PR. In particular, the use of a 50?μm thick methacrylic matrix containing 8% (S)-PR and 15% NMP can allow to develop a patch non-irritating to the skin, in order to ensure a constant permeation flux of PR over 48?h.     

Absorptive Capacity,Proximity in Cooperation and Integration Mechanisms. Empirical Evidence from CIS Data

The paper extends available findings on the antecedents and impact of the firm's absorptive capacity. Innovation cooperation is recognized as a driver of its potential side (PAC). Considering different forms of proximity, we expect to find a higher impact for interactions occurring between close partners. Human capital (HC) is expected to be as important as other organizational mechanisms for the innovation impact of PAC. An empirical application with Community Innovation Survey data confirms these arguments only partially. The firm's cooperation with geographically closer partners (i.e., in the same country) increases its PAC, but it is cooperation with institutionally distant ones (e.g., research organizations) that augments it. Among the integration mechanisms of external knowledge, those increasing the firm's HC are the only ones that positively moderate the innovation impact of PAC.